Windtree Therapeutics, Inc.
WINT
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.66M | -16.05M | -1.79M | -9.71M | -11.38M |
| Total Depreciation and Amortization | -192.00K | -185.00K | -181.00K | -89.00K | -132.00K |
| Total Amortization of Deferred Charges | -98.00K | 157.00K | 157.00K | 60.00K | 60.00K |
| Total Other Non-Cash Items | -1.41M | -455.00K | -14.96M | -7.01M | -5.36M |
| Change in Net Operating Assets | 1.17M | 1.67M | 1.37M | 1.46M | 4.12M |
| Cash from Operations | -15.19M | -14.86M | -15.40M | -15.28M | -12.69M |
| Capital Expenditure | 0.00 | -12.00K | -12.00K | -12.00K | -27.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.18M | -- | -- | -- | -- |
| Cash from Investing | -5.18M | -12.00K | -12.00K | -12.00K | -27.00K |
| Total Debt Issued | 7.75M | 2.11M | 1.86M | 1.86M | 1.66M |
| Total Debt Repaid | -1.51M | -738.00K | -805.00K | -928.00K | -700.00K |
| Issuance of Common Stock | 15.64M | 15.20M | 14.28M | 10.42M | 2.12M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -2.36M | -2.36M | -1.88M | -847.00K | -- |
| Total Dividends Paid | -747.00K | -747.00K | -657.00K | -347.00K | -- |
| Other Financing Activities | 100.00K | 32.00K | -68.00K | -68.00K | -168.00K |
| Cash from Financing | 18.88M | 13.50M | 12.73M | 10.09M | 2.92M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.50M | -1.37M | -2.68M | -5.21M | -9.81M |